Merck & Co., Inc. (MRK) — Analyst outlook / Analyst consensus target is. Based on 37 analyst ratings, the consensus is bullish — 25 Buy, 11 Hold, 1 Sell.
The consensus price target is $128.54 (low: $100.00, high: $150.00), representing an upside of 7.2% from the current price $119.96.
Analysts estimate Earnings Per Share (EPS) of $7.53 and revenue of $63.99B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $6.74 vs est $7.53 (missed -10.5%). 2025: actual $7.28 vs est $8.93 (missed -18.5%). Analyst accuracy: 83%.
MRK Stock — 12-Month Price Forecast
$128.54
▲ +7.15% Upside
Average Price Target
Based on 37 Wall Street analysts offering 12-month price targets for Merck & Co., Inc., the average price target is $128.54, with a high forecast of $150.00, and a low forecast of $100.00.
The average price target represents a +7.15% change from the last price of $119.96.
Highest Price Target
$150.00
Average Price Target
$128.54
Lowest Price Target
$100.00
MRK Analyst Ratings
Buy
Based on 37 analysts giving stock ratings to Merck & Co., Inc. in the past 3 months
EPS Estimates — MRK
83%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $6.74
vs Est $7.53
▼ 11.7% off
2025
Actual $7.28
vs Est $8.93
▼ 22.7% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving.
Revenue Estimates — MRK
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $64.168B
vs Est $63.985B
▲ 0.3% off
2025
Actual $65.011B
vs Est $64.850B
▲ 0.2% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
